Journal of Pregnancy and Child Health
Open Access

Research Article

Response to Hydrolysed Collagen Protein Supplementation in a Cohort of Pregnant and Postpartum Women

Leon Baginski¹, Marc Winter², Thomas S Bailey³, Scott Capobianco⁴, Marsha Granese⁵, Freddie Granger MA⁶, Kurt Miller⁷, Kerry Price⁸, Sara Ramirez⁹, Craig Salcido¹⁰, Frank Turner^11* and Mary O’Toole¹²

¹Mission Obstetrics and Gynaecology, Mission Viejo, California and Orange Coast Women’s Medical Group, Laguna Hills, California, USA

²University of California College of Medicine, Orange Coast Women's Medical Group, Laguna Hills, CA, USA

³University of Arizona Medical School, Mission OBGYN Medical Group, Mission Viejo CA, USA

⁴Medical School, Mission OBGYN Medical Group, Mission Viejo, CA, USA

⁵St. George's University, Mission OBGYN Medical Group, Mission Viejo, USA

⁶Mission Ob/Gyn Medical, Mission Viejo California, USA

⁷University of San Diego School of Medicine, Mission OBGYN Medical Group, Mission Viejo, USA

⁸University of Chicago Pritzger School of Medicine, Orange Coast Women's Medical Group, Laguna Hills, CA, USA

⁹University of Chicago Medical School, Mission OBGYN Medical Group, Mission Viejo, CA, USA

¹⁰University of New York Medical College, Mission OBGYN Medical Group, Mission Viejo, CA, USA

¹¹Innovative Research Associates 415 Elmwood Ave, Sharon Hill, PA, USA

¹²Chicago Medical School, Orange Coast Women's Medical Group, Laguna Hills, CA, USA

*Corresponding Author:

Frank Turner
Innovative Research Associates 415 Elmwood Ave
Sharon Hill, PA, USA
Tel: 5403168030
E-mail: neuroma7@msn.com

Received Date: August 21, 2016; Accepted Date: September 26, 2016; Published Date: September 30, 2016

Citation: Baginski L, Winter M, Bailey TS, Capobianco S, Granese M, et al. (2016) Response to Hydrolysed Collagen Protein Supplementation in a Cohort of Pregnant and Post-Partum Women. J Preg Child Health 3: 275. doi:10.4172/2376-127X.1000275

Copyright: © 2016 Bakginski L, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

There is overwhelming evidence that links maternal nutrition during pregnancy with fetal outcomes. This study evaluated the safety and efficacy of Protiva treatment responses in pre and postpartum female subjects between the ages of 19 years and 43 years who entered into this open label study. The protocol was designed to take a twice daily collagen protein supplementation drink during the third trimester and for 10 weeks postpartum. The outcomes were measured against a control group of patients who did not take the protein supplementation. The differences between mean score for the physical health domain of WHOQOL-BREF scale in the Protiva group and the control group were different and met statistical significance (p=0.0003). The study found that 100% of control patients and 95% of Protiva patients had initial serum protein levels below the normal median range and 27% of control patients and 33% of Protiva patients were below normal range. With collagen protein supplementation we were able to demonstrate improved quality of life and wound healing rates and 100% improvement in the protein levels for Protiva patients and a 72% improvement over control patients. Protiva Pregnancy and Protiva New Mom was determined to be safe and well tolerated when taken during pregnancy and post-partum during the study.

Keywords